Mereo Biopharma Group Plc ADR (MREO): Next-Year EPS Estimate 32.68%
As of 2026-06-11, Mereo Biopharma Group Plc ADR (MREO) has a next-year EPS growth estimate of 32.68%.
On 2026-05-13, analyst consensus for MREO's next-year EPS growth shifted from 91.46% to 32.68% — a negative change of 58.78 percentage points. The revised estimate has been sustained across 22 subsequent trading sessions. Current-year growth is projected at 76.67%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 32.68%
- EPS growth this year
- 76.67%
- EPS next quarter (est)
- -$0.01
- Last price
- $0.31
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 32.68% | 76.67% | -$0.01 | $0.31 |
| 2026-06-10 | 32.68% | 76.67% | -$0.01 | $0.30 |
| 2026-06-09 | 32.68% | 76.67% | -$0.01 | $0.31 |
| 2026-06-08 | 32.68% | 76.67% | -$0.01 | $0.31 |
| 2026-06-07 | 32.68% | 76.67% | -$0.01 | $0.31 |
| 2026-06-04 | 32.68% | 76.67% | -$0.01 | $0.32 |
| 2026-06-03 | 32.68% | 76.67% | -$0.01 | $0.33 |
| 2026-06-02 | 32.68% | 76.67% | -$0.01 | $0.34 |
| 2026-06-01 | 32.68% | 76.67% | -$0.01 | $0.31 |
| 2026-05-31 | 32.68% | 76.67% | -$0.01 | $0.34 |
| 2026-05-28 | 32.68% | 76.67% | -$0.01 | $0.34 |
| 2026-05-27 | 32.68% | 76.67% | -$0.01 | $0.33 |
| 2026-05-26 | 32.68% | 76.67% | -$0.01 | $0.33 |
| 2026-05-25 | 32.68% | 76.67% | -$0.01 | $0.28 |
| 2026-05-24 | 32.68% | 76.67% | -$0.01 | $0.28 |
| 2026-05-21 | 32.68% | 76.67% | -$0.01 | $0.27 |
| 2026-05-20 | 32.68% | 76.67% | -$0.01 | $0.28 |
| 2026-05-19 | 32.68% | 76.67% | -$0.01 | $0.24 |
| 2026-05-18 | 32.68% | 76.67% | -$0.01 | $0.24 |
| 2026-05-17 | 32.68% | 76.67% | -$0.01 | $0.24 |
| 2026-05-14 | 32.68% | 76.67% | -$0.01 | $0.25 |
| 2026-05-13 | 32.68% | 76.67% | -$0.01 | $0.25 |
| 2026-05-12 | 91.46% | 66.67% | -$0.02 | $0.25 |
| 2026-05-11 | 78.64% | 86.67% | -$0.01 | $0.24 |
| 2026-05-10 | 78.64% | 86.67% | -$0.01 | $0.25 |
| 2026-05-07 | 78.64% | 86.67% | -$0.01 | $0.24 |
| 2026-05-06 | 78.64% | 86.67% | -$0.01 | $0.24 |
| 2026-05-05 | 78.64% | 86.67% | -$0.01 | $0.28 |
| 2026-05-04 | 78.64% | 86.67% | -$0.01 | $0.29 |
| 2026-05-03 | 78.64% | 86.67% | -$0.01 | $0.26 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Mereo Biopharma Group Plc ADR's next-year EPS growth estimate?▾
As of 2026-06-11, Mereo Biopharma Group Plc ADR (MREO) has a next-year EPS growth estimate of 32.68%, based on analyst consensus.
When was the latest EPS estimate revision for MREO?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 91.46% to 32.68%.
What sector and industry does Mereo Biopharma Group Plc ADR belong to?▾
Mereo Biopharma Group Plc ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. MREO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Mereo Biopharma Group Plc ADR (MREO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports